Conference News Conference News Daily digests from key neurology conferences, written by on-site medical journalists. Published: May 26, 2020

Eculizumab retains efficacy in NMOSD despite differences in standard of care

Eculizumab has a meaningful effect on relapse in AQP4-IgG4+ neuromyelitis optica spectrum disorder (NMOSD) despite differences in standard of care between regions, according to an international research group.